Personalized Approaches to Sustained Biologic Remission in CROHN'S DISEASE-Houston, TX
This initiative has been designed to increase knowledge and competence and the participant’s ability to:
1. Increase the frequency of colonoscopy or other imaging modalities prior to and following the initiation of a biologic therapy in patients with CD
2. Increase the utilization of mucosal healing as a therapeutic endpoint in clinical practice
1. Introductory Remarks
2. Endoscopy for the Assessment of Mucosal Healing
a. The relationship between endoscopic improvement and treatment outcomes
b. Endoscopic disease scoring scales in CD
c. The relationship between treatment and achievement of mucosal healing
3. Novel Techniques to Assess Mucosal Healing: Radiology & Biomarkers
b. Capsule Endoscopy
c. C-reactive protein
4. Individualizing Therapy for Patients with Crohn’s Disease
a. Symptoms relief vs. endoscopic findings
b. Prognostic stratification
c. Therapeutic drug monitoring
d. ‘Step-up’ vs ‘Top-down’ treatment approaches
5. Concluding Remarks and Audience Q & A
Acknowledgement of Commercial Support
This activity is supported by independent educational grants from AbbVie, Prometheus, and UCB, Inc.
These activities have been designed to meet the educational needs of gastroenterologists and other health care professionals involved in the care of patients with Crohn’s disease (CD).
At the conclusion of these activities, participants will be able to:
- Discuss the clinical benefits of mucosal healing in patients with CD;
- Design an effective treatment plan that maximizes the occurrence of mucosal healing in patients with CD;
- Evaluate the clinical utility of colonoscopy, non-invasive imaging techniques, and biomarkers for the assessment of mucosal healing in patients with CD.
David T. Rubin, MD, FACG, AGAF, FACP
The Joseph B. Kirsner Professor of Medicine
Chief, Section of Gastroenterology, Hepatology and Nutrition
The University of Chicago Medicine
William J. Sandborn, MD
Professor of Medicine and Adjunct Professor of Surgery
Chief, Division of Gastroenterology
Director, UCSD IBD Center
University of California, San Diego and UC San Diego
La Jolla, CA
Andrew W. DuPont, MD, MSPH
Director, Clinical Investigation in Gastroenterology
Director, Inflammatory Bowel Disease Program
Associate Professor, Gastroenterology, Hepatology and Nutrition
University of Texas Health Center
Bincy P. Abraham, MD, MS, FACG
Director, Fondren IBD Program
Director, GI Fellowship Program
Houston Methodist Hospital
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the ACCME through the joint providership of The University of Chicago Pritzker School of Medicine, FACTORx, and MedEd Consulting. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
The information presented at this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient’s medical condition.
For complete activity information, visit the conference website or download the brochure below.
REGISTRATION IS NOT OPEN TO THE PUBLIC